🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
This phase II trail will evaluate the efficacy and safety of combining gemc...
Status
Recruiting
Location
Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University
Start Date
2024-10-24
Trial ID
NCT06591650
Treatments Being Tested
This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2026-06-16
Trial ID
NCT07629817
In view of the existence of malignant ascites in patients with advanced pan...
Status
Unknown
Location
Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Start Date
2021-02-23
Trial ID
NCT04707118
Treatments Being Tested
This multicentre, randomized controlled trial evaluates the effect and safe...
Status
Recruiting
Location
Guangdong Provincial Hospital of Chinese Medicine
Start Date
2026-01-15
Trial ID
NCT07337096
Treatments Being Tested
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
This is a phase II study to assess the efficacy, safety, and Health Related...
Status
Recruiting
Location
Ryan Nguyen
Start Date
2022-12-28
Trial ID
NCT05613413
Treatments Being Tested
This is a multicenter phase II clinical study to explore the efficacy, safe...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2025-04-30
Trial ID
NCT06869226
Treatments Being Tested
This study aims to evaluate the efficacy and safety of induction Adebrelima...
Status
Not Yet Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2025-08-10
Trial ID
NCT07112833
This is a phase II open-label study evaluating the efficacy and safety of n...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2019-07-15
Trial ID
NCT03915444
Treatments Being Tested